A kidney biopsy for research

From: Cross-Match Kidney Transplant 101:

• Donor #1 and I matched on blood type and 5 out of 8 key genetic and antibody markers.
• Donor #2 (Jeff) and I matched on 4 out of the 8 key genetic and antibody markers.

At the time, I didn’t fully understand what those numbers meant, but they became part of the reason I now understand how fragile and remarkable a match can be.

Yesterday, I underwent a research biopsy. Not because something was wrong with my transplanted kidney, but because something was, miraculously, right. My theory, things were right due to previous biopsies. I returned to the same place where my life was handed back to me, not to receive, but to pay it forward. Five months ago, I had volunteered to contribute a sample at my six‑month post‑transplant mark. Those early genetic differences between Donor #1 and Donor #2 stayed with me, and they became part of why I was able to say a ‘yes’ of my own. If small variations in markers could determine whether a kidney thrives or struggles, then research like this biopsy might help future recipients understand their own matches with greater clarity.

Before I became a willing volunteer:
When I walked into the UNMC transplant center/Clarkson Hospital last October, I wasn’t thinking about science. I wasn’t thinking about datasets, research studies, or the future of medicine. I was thinking about breathing without exhaustion, about eating dinner with my family without calculating how much time I had before my next dialysis cycle.

At that time, it was all more than enough to handle.

But somewhere during my transplant recovery, a shift happened. In the earliest weeks, survival was everything. Every lab result felt like a weekly verdict. Each kind of unusual pain sent my mind to places I did not want to revisit. I was too focused on keeping this extraordinary gift alive. That is human nature. As the weeks passed, the fog lifted. The numbers stabilized. I’d sleep through the night and started making plans again.

Then gratitude started looking for places to go. It stopped being less of an emotion and more of a question. What does a person do when grace hands them a second chance and whispers, “Use this well”? For me, Tuesday’s biopsy became a small yes, a way to step into a story of generosity that started long before my name was ever part of it.

To some, an elective biopsy might seem unnecessary. Why go through discomfort when things are going well? I understand that. But this journey is not only about my healing. It is about smoothing the path for the next person trying to find a living donor match. When I thought about that, my decision became simple.

The procedure itself was straightforward. With local anesthesia and a somewhat long needle guided by ultrasound, the team collected a tiny sample of tissue in a process that moved with calm efficiency. The procedure took about an hour. Was it comfortable? Not exactly. The gel on my skin felt colder than I expected, the numbing shot came with a burning sensation I braced for, and the ultrasound wand pressed with clinical firmness. The machine hummed in a low, constant tone. When the needle clicked into place, it was more pressure than pain, a sharp tap that made me hold my breath without meaning to. Was it something to lose sleep over? Less than you would think.

As I lay there, the people who would one day seek a donor came to mind, hoping for answers, hoping for a match, hoping for more time. That lingering thought stayed with me long after the biopsy ended. I also pictured the ones who had gone before me, too, those willing to give up a similar hour so that other transplant recipients could have their best chance at a long‑lasting kidney.

When researchers study this kidney sample, they are not only collecting data. They are tracing the fingerprints, learning how a stranger’s organ can take root in a new body and call it home.

Sometimes God lets us study His mysteries under a microscope.

When a donor kidney enters a recipient’s body, a conversation begins. The immune system has to decide whether this new organ is a friend or a threat. Rejection is what happens when that negotiation fails. Success happens when the body chooses welcome over war. The study I joined is trying to decode that conversation at a cellular level. Researchers want to identify the markers that distinguish a thriving match from one that is struggling, ideally before traditional tests can detect a problem. That is precision medicine. My kidney becomes part of that picture. A small piece of tissue can tell a story that blood tests cannot. And those stories can extend the future of those with chronic kidney disease.

Adding a link in the chain for research:
I had signed up to be included in this study as someone before me had done the same. Not my donor. Not Jeff. Someone I will never know, and many more whose names I will never learn. Someone who once sat in a hospital, not unlike the one I sat in on Tuesday, after previously agreeing to let researchers study their kidney so that future recipients might have a better chance. They didn’t do it for applause, and they never knew whose life their yes would touch. And it became part of the science that made my transplant and others possible.

Because of the research participants who came before me, doctors understand more about how matches work. They can identify risks earlier. They can adjust medications with greater precision. The paired donation pathway that connected me to my kidney did not happen by accident. It happened because someone, somewhere, chose to give before they knew who would receive.

That is what Tuesday was for me.

I did not need this biopsy for my own care. If the data from my kidney helps one future recipient find a better match, that alone is worth it. And if it helps a researcher ask a better question, that is worth it too. I thought about the exam table beneath me, the hum of the ultrasound machine still in my ears, and how many people before me had made the same choice. Knowing that this small sample might contribute to a transplant in 2030, having a higher chance of lasting a lifetime was its own kind of clarity. A morning at the hospital felt small compared to the grace I’ve been given.

The chain of giving does not have to stop at the operating table.

It can stretch into the research lab, move through the data, and reach into the future of kidney transplants that have not even been imagined yet. Grace does not end where the incision heals. I was there to give, to add my small link to a continuum of selfless generosity that started long before me and will continue long after. Some sanctuaries glow with stained glass. Mine held vinyl chairs, a folded gown, and a blood pressure cuff.

If you have been approached about joining a research study and you are on the fence, I hope my account and reflection help. This journey started with a stranger’s courage, and I will never be able to thank them in person.

Now it was my turn.

Have you taken part in a transplant research study as a recipient or donor? I would love to hear about your experience in the comments below.

Related Post:
Matching Clinical Kidney Trials – Jeff

Share on Facebook